Physician profile
Manuel Cortes
NPI 1861898801
$8,847.79
in general payments reported to CMS, 2019-2025
37 companies · $2,560 in 2025
The $2,560 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $212 · 2021: $215 · 2022: $1,341 · 2023: $2,481 · 2024: $1,758 · 2025: $2,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,750 · Travel and Lodging: $48.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,750.21 |
| Travel and Lodging | $48.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,356.93 | 2021-2025 | Onyx Frontier, Symplicity G3, Linq II |
| Abbott Laboratories | $701.50 | 2020-2025 | Amplatzer, Epic, Absolute Pro |
| Shockwave Medical, INC | $694.33 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $663.99 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $541.60 | 2019-2025 | Lifevest |
| Atricure, INC. | $452.46 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $340.55 | 2022-2023 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $297.01 | 2019-2023 | |
| Inari Medical, INC. | $289.09 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $283.44 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.43 | 2022-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $241.98 | 2022-2023 | |
| Medtronic Vascular, INC. | $228.41 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $209.61 | 2022-2023 | Xarelto |
| Pfizer INC. | $175.83 | 2022-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $129.45 | 2025 | Indigo System |
| W. L. Gore & Associates, INC. | $122.39 | 2022-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Endoprosthesis |
| Stryker Corporation | $119.94 | 2025 | Flowtriever, Artix Mt, Ct Thrombectomy System Kit |
| Inspire Medical Systems, INC. | $114.45 | 2023 | Inspire |
| Amgen INC. | $111.42 | 2022-2023 | Repatha |
| Philips North America LLC | $57.97 | 2022-2023 | |
| Cardiva Medical, INC. | $57.14 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Merck Sharp & Dohme LLC | $52.92 | 2022-2023 | Verquvo |
| Irhythm Technologies, INC. | $50.22 | 2022-2023 | Zio Xt Patch |
| Angiodynamics, INC. | $49.63 | 2023 | Alphavac |
| Cardiovascular Systems INC. | $39.28 | 2020 | |
| Imperative Care, INC | $34.79 | 2025 | Symphony Catheter |
| Baxter Healthcare | $28.57 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Biotronik INC. | $22.80 | 2023 | Pk Papyrus |
| Terumo Medical Corporation | $21.82 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.04 | 2023 | Inpefa |
| Medicomp INC | $16.60 | 2023 | Telepatch Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $16.39 | 2023 | Onpattro |
| Elutia, INC. | $14.29 | 2024 | Ecm Patch,Pouch |
| Impulse Dynamics (USA) INC. | $14.28 | 2023 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $14.19 | 2023 | Farxiga |
| Esperion Therapeutics, INC. | $14.05 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Cortes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.